Rob Maloney: Why Global Diagnosis is the Missing Piece in Bleeding Disorder Care
Rob Maloney, Chief Executive Officer of Hemophilia of Georgia, shared a post on LinkedIn:
“At a recent World Federation of Hemophilia conference, leaders from more than 130 countries gathered to discuss the future of bleeding disorder care.
There were presentations on new therapies.
Research breakthroughs.
Global partnerships.
All important.
But one statistic stayed with me.
Not treatment.
Diagnosis.
Worldwide, hundreds of thousands of people living with bleeding disorders still have not been identified.
Think about that for a moment.
You cannot treat a condition that hasn’t been diagnosed.
You cannot connect a family to resources they don’t know exist.
You cannot provide hope to someone who doesn’t yet have a name for what they’re experiencing.
For all the innovation happening in healthcare, diagnosis remains one of our greatest opportunities.
That’s true globally.
It’s also true here at home.
One of our goals is to help connect people with bleeding disorders to diagnosis, care, and resources as early as possible.
Because behind every diagnosis is a family looking for answers.
And often, the most important step in their journey isn’t treatment.
It’s finally knowing what they’ve been dealing with all along.”
Other posts featuring Rob Maloney on Hemostasis Today.
-
Sep 13, 2026, 16:09Dimitrios Syrengelas: Haemophilia Care Begins With Safe Movement
-
Sep 13, 2026, 15:33Christina (Tina) P.: Antiphospholipid Syndrome After Unprovoked VTE
-
Sep 13, 2026, 15:22Ioana Alexandra Voda: The Story Gets More Time at IFOS Istanbul
-
Sep 13, 2026, 14:52Omar Al Hammadi: Integrating Diabetes and Dyslipidemia in Modern Clinical Care
-
Sep 13, 2026, 14:37Mohammad Zamrood Khan: Hereditary Spherocytosis and Protein C/S Deficiency Case Report Submitted
-
Sep 13, 2026, 14:33Heghine Khachatryan: A Resource-Adapted Approach to Hemophilia Joint Care
-
Sep 13, 2026, 14:23Simon Fletcher: The Unmet Burden of Factor VII Deficiency
-
Sep 13, 2026, 14:10Azusa Nagao: The Evolving Burden of Haemophilia Prophylaxis
-
Sep 13, 2026, 13:50Priya Sriskandarajah: The Challenge of Thrombotic Risk in Myeloproliferative Neoplasms